2024
|
Invention
|
Bacteria-based protein delivery.
The present invention relates to recombinant Gram-negative bact... |
|
P/S
|
Software, software used for running applications; electronic
agendas. Collection, systematizatio... |
|
Invention
|
Probe support structure for a micrometer-scale and/or nanometer-scale measuring device. The inven... |
|
Invention
|
Hybrid triblock copolymer membrane compositions and methods for nanopore sequencing. This applica... |
|
Invention
|
Manipulating device. A manipulating device (1) for manipulating an object comprises a body unit (... |
|
Invention
|
Discernible cell surface protein variants of cd33 for use in cell therapy. The present disclosure... |
|
Invention
|
Manufacturing 2,3,5-trimethylhydroquinone from a mixture of mesitol and 2,3,6-trimethylphenol. Th... |
2023
|
Invention
|
Antibodies targeting cd45. The present disclosure relates to antibodies and antibody fragments th... |
|
Invention
|
Treatment of neurological disorders.
The present invention is relates to a compound of formula (... |
|
Invention
|
B1a subunit and uses thereof. BBR1a receptors and uses thereof. |
|
Invention
|
Medical endodevice. A medical endodevice (1) for an intervention inside a body cavity (54) of a b... |
|
Invention
|
An all-optical quantum sensor for magnetic fields. The invention relates to a quantum spin-based ... |
|
Invention
|
Immunosuppressive compounds. The present invention relates to a compound of formula (I) or a phar... |
|
Invention
|
Microinvasive surgery device. A microinvasive surgery device (10) comprising a body element (20),... |
|
Invention
|
Deep neural network based method for electromagnetic source image reconstruction. The present inv... |
|
Invention
|
Bacterial vaccine comprising probiotic competitor and inactivated pathogen. The invention relates... |
|
Invention
|
Mr1 restricted t cell receptors for cancer immunotherapy.
Described herein is a method of isolat... |
|
Invention
|
Antibodies targeting cd117. The present disclosure relates to antibodies and antibody fragments t... |
|
Invention
|
Entry-modulating agents and uses therefor. This disclosure relates generally to the use of compou... |
|
Invention
|
Nanomechanical profiling of breast cancer molecular subtypes. The invention relates to a method f... |
|
Invention
|
Bruxism detection device and method of configuring such device. A bruxism detection device (1) co... |
|
Invention
|
Nano plasma membrane vesicle production process. The invention relates to a method to obtain a pr... |
|
Invention
|
Mucin glycans as antifungal agents.
The disclosure provides, in various embodiments, methods of ... |
|
Invention
|
Mucin glycans as antifungal agents. The disclosure provides, in various embodiments, methods of t... |
|
Invention
|
Cellular therapy. The invention is in the field of regenerative medicine and provides composition... |
|
Invention
|
Pi3k/akt/mtor inhibitor for improving the cellular uptake of a radiopharmaceutical. The present i... |
|
Invention
|
Novel proteins and nucleic acid sequences and use thereof in the prophylaxis and/or treatment of ... |
|
Invention
|
Salicylic acid compositions and uses thereof. E. coliE. coli infections and in particular recurre... |
2022
|
Invention
|
Discernible cell surface protein variants of cd45 for use in cell therapy. The present disclosure... |
|
Invention
|
Discernible cell surface protein variants of cd117 for use in cell therapy. The present disclosur... |
|
Invention
|
Hafnium (iv) oxide nanoparticles and aqueous compositions thereof.
The invention relates to a ha... |
|
Invention
|
Virulence attenuated bacteria based protein delivery.
The present invention relates to recombina... |
|
Invention
|
Targeting snx9 rescues recombinant t cell in adoptive therapy. A first aspect of the invention re... |
|
Invention
|
Allele editing and applications thereof.
The invention relates to a method to determine a homolo... |
|
Invention
|
Mesenchymal stem cell line.
A mesenchymal stem/stromal (MSC) cell line, in particular a human me... |
|
Invention
|
Method for identifying pi3 kinase-alpha inhibitors.
The invention relates to a method of identif... |
|
Invention
|
Triazine derivative as covalent inhibitors of pi3k.
Kinase-targeted covalent inhibitors are usua... |
|
Invention
|
Triazine derivative as reversible and irreversible covalent inhibitors of pi3k.
Our invention re... |
|
Invention
|
Device for modelling a blood labyrinth barrier.
A device is disclosed for modelling a blood laby... |
|
Invention
|
Compositions for the treatment of ebv associated diseases or conditions.
The invention relates t... |
|
Invention
|
Viral delivery of a sialidase to treat cancer.
The present invention relates to adenovirus-assoc... |
2021
|
Invention
|
Photooxidation of 2,4,6-trimethylphenol.
The present invention relates to the photooxidation of ... |
|
Invention
|
Endodevice.
An endodevice is disclosed with tension control. The endodevice includes a back end ... |
|
Invention
|
[161tb]-based radiopeptides.
A radiopeptide is provided which comprises (a) a radionuclide, wher... |
|
Invention
|
Hemostatic elastin-like polypeptides.
The present invention relates to a hemostatic elastin-like... |
|
Invention
|
Lfa-1 signalling mediator for use in cancer therapy.
The present invention relates to an LFA-1 s... |
|
Invention
|
Single photon source for generating bright and coherent single photons.
The present invention re... |
|
Invention
|
Device-independent quantum key distribution.
The invention relates to a method for device-indepe... |
2013
|
P/S
|
Bookbinding material; printed matter; instructional or
teaching material (except apparatus); pre... |